U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07626515) titled 'A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants' on June 01.
Brief Summary: This is a Phase I, randomized, double-blinded, placebo-controlled, study to assess the safety, tolerability, and pharmacokinetics (PK) of enicepatide in generally healthy adult Chinese participants with body mass index (BMI) >=23.0 kilograms per meter squared (kg/m^2).
Study Start Date: June 26
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
COMBINATION_PRODUCT: Enicepatide
Participants will receive enicepatide via subcutaneous (SC) injection as per t...